Northcape Wealth Management’s AstraZeneca AZN Stock Holding History

Northcape Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$340K	Hold	1,725	–	–	0.09%	112
2025 Q4	$317K	Hold	1,725	–	–	0.09%	118
2025 Q3	$265K	Hold	1,725	–	–	0.08%	124
2025 Q2	$241K	Hold	1,725	–	–	0.07%	129
2025 Q1	$254K	Hold	1,725	–	–	0.08%	125
2024 Q4	$226K	Hold	1,725	–	–	0.07%	128
2024 Q3	$269K	Hold	1,725	–	–	0.09%	122
2024 Q2	$269K	Buy	+1,725	New	+$260K	0.1%	121
2024 Q1	–	Sell	-1,725	Closed	-$232K	–	134
2023 Q4	$232K	Hold	1,725	–	–	0.08%	125
2023 Q3	$234K	Hold	1,725	–	–	0.09%	131
2023 Q2	$247K	Hold	1,725	–	–	0.09%	139
2023 Q1	$239K	Buy	+1,725	New	+$232K	0.09%	135
2022 Q3	–	Sell	-1,725	Closed	-$228K	–	137
2022 Q2	$228K	Sell	1,725 -25	-1%	-$3.28K	0.09%	112
2022 Q1	$232K	Sell	1,750 -250	-13%	-$30K	0.07%	140
2021 Q4	$233K	Buy	+2,000	New	+$235K	0.08%	119

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Northcape Wealth Management's AZN Position: Q1 2026 in Review

Northcape Wealth Management held its AstraZeneca (AZN) position steady in Q1 2026 at 1,725 shares worth $340K. The position accounts for 0.09% of the portfolio, ranked #112.

Northcape Wealth Management first reported a position in AZN in Q4 2021 and has held it in 15 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Northcape Wealth Management held 1,725 shares of AstraZeneca worth $340K as of Q1 2026.
Northcape Wealth Management left its AstraZeneca share count unchanged in Q1 2026.
AstraZeneca made up 0.09% of Northcape Wealth Management's portfolio in Q1 2026, its #112 holding.
Northcape Wealth Management first reported a position in AstraZeneca in Q4 2021 and has held it in 15 quarters since.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Northcape Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.